BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36897366)

  • 41. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascularized free tissue transfer for reconstruction of ablative defects in oral and oropharyngeal cancer patients undergoing salvage surgery following concomitant chemoradiation.
    Arce K; Bell RB; Potter JK; Buehler MJ; Potter BE; Dierks EJ
    Int J Oral Maxillofac Surg; 2012 Jun; 41(6):733-8. PubMed ID: 22483447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of heavily pretreated recurrent oral squamous cell carcinoma after salvage resection: A monocentric retrospective analysis.
    Horn D; Bodem J; Freudlsperger C; Zittel S; Weichert W; Hoffmann J; Freier K
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1061-6. PubMed ID: 27255408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extent of Extranodal Extension in Oral Cavity Squamous Cell Carcinoma is Not Independently Associated With Overall or Disease-Free Survival at a 2.0-mm Threshold.
    Best DL; Jazayeri HE; McHugh JB; Udager AM; Troost JP; Powell C; Moe J
    J Oral Maxillofac Surg; 2022 Dec; 80(12):1978-1988. PubMed ID: 36179764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between postoperative complications and survival after free flap reconstruction for oral cavity squamous cell carcinoma.
    Ch'ng S; Choi V; Elliott M; Clark JR
    Head Neck; 2014 Jan; 36(1):55-9. PubMed ID: 23559547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
    Melo GM; Guilherme LH; Palumbo MDN; Rosano M; Neves MCD; Callegari FM; Abrahao M; Cervantes O
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S152-S162. PubMed ID: 35042657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.
    Goto M; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hyodo I; Kodaira T; Ogawa T; Fujimoto Y; Terada A; Kato H; Hasegawa Y
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e141-8. PubMed ID: 23909955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma.
    Chen TC; Lo TH; Huang HC; Wang CW; Yang TL; Lou PJ; Ko JY; Wang CP
    Head Neck; 2021 Dec; 43(12):3764-3774. PubMed ID: 34510614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.
    Chen TH; Pan YY; Lee TL; Wang LW; Tai SK; Chu PY; Lo WL; Wu CH; Yang MH; Chang PM
    BMC Cancer; 2022 Dec; 22(1):1336. PubMed ID: 36539738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?
    Gleich LL; Ryzenman J; Gluckman JL; Wilson KM; Barrett WL; Redmond KP
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):35-8. PubMed ID: 14732765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
    Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
    Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of Regional Recurrence and Salvage Treatment in Patients With Oral Cancer.
    Yosefof E; Hilly O; Stern S; Bachar G; Shpitzer T; Mizrachi A
    Laryngoscope; 2022 Apr; 132(4):786-792. PubMed ID: 34397102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncological safety of submental island flap for reconstruction of pathologically node-negative and node-positive T1-2 oral squamous cell carcinoma-related defects: A retrospective study and comparison of outcomes.
    Wang J; Tan Y; Shen Y; Lv M; Li J; Sun J
    Oral Oncol; 2020 Mar; 102():104507. PubMed ID: 31896500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes and prognostic factor analysis after salvage surgery for recurrent squamous cell carcinoma of the oral cavity.
    Chung EJ; Park MW; Kwon KH; Rho YS
    Int J Oral Maxillofac Surg; 2020 Mar; 49(3):285-291. PubMed ID: 31492478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.